GlassScriptPhysician profile
Bradley J Schmitz
NPI 1447273990
$3,296.55
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,848 · 2020: $248 · 2023: $134 · 2024: $66.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $323.86 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $285.35 | 2019 | |
| Amgen INC. | $272.53 | 2019-2020 | |
| Pfizer INC. | $248.56 | 2019 | |
| Novo Nordisk INC | $212.90 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $192.88 | 2019 | |
| Merck Sharp & Dohme LLC | $158.14 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $153.57 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $133.91 | 2023 | |
| Daiichi Sankyo INC. | $132.96 | 2019-2020 | |
| Lilly USA, LLC | $115.06 | 2019 | |
| Sunovion Pharmaceuticals INC. | $113.62 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $103.02 | 2019-2020 | |
| Abbvie INC. | $91.93 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $74.08 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $74.02 | 2019 | |
| Novartis Pharmaceuticals Corporation | $69.30 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.60 | 2024 | |
| Genentech USA, INC. | $61.55 | 2019 | |
| Astellas Pharma US INC | $57.84 | 2019 | |
| Amarin Pharma, INC. | $47.40 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $45.56 | 2019 | |
| Antares Pharma, INC. | $36.40 | 2019 | |
| Ironwood Pharmaceuticals, INC | $34.92 | 2019 | |
| Bausch Health US, LLC | $33.67 | 2019 | |
| Collegium Pharmaceutical, INC. | $28.65 | 2019-2020 | |
| Intuitive Surgical, INC. | $28.52 | 2019 | |
| Allergan, INC. | $27.60 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $26.95 | 2019-2020 | |
| Philips North America LLC | $16.92 | 2019 | |
| Mylan Specialty L.P. | $15.78 | 2019 | |
| Hikma Pharmaceuticals USA | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Schmitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.